eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
. may 17, 2018
.
40 under 40 - bbj class of 2018
.: joe khamisi book ‘looters and grabbers’ not sold in kenyan stores
.